Plenary: 2101 Immunotherapy: Mechanism, Outcomes and Markers

AMA PRA Category 1 Credits^TM: 1.50
CE: 1.80

Upon completion of this session, participants should be able to:

• Discuss the benefits of specific immunotherapy.
• Describe factors affecting safety of specific allergy immunotherapy.
• Discuss the use of biomarkers to predict the response to immunotherapy to pollens.

Credit must be claimed by May 31, 2016. Any credit request on or after June 1, 2016 will be subject to an administrative fee.